the Efficacy and Safety of Diosmin in Patients With Ulcerative Colitis
Status:
Not yet recruiting
Trial end date:
2024-11-01
Target enrollment:
Participant gender:
Summary
This is a randomized, controlled study evaluating diosmin tablets administered daily for 3
months. The purpose of the study is to evaluate the efficacy and safety of diosmin in the
treatment of mild to moderately active ulcerative colitis. Disease activity will be measured
using modified truelove and witt's classification.